Patent · US Expired

Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections

US6328954A · kind A · utility

6Cited by

5References

14Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Karlheinz Enssle · Marburg, DE
Roland Kurrle · Frankfurt am Main, DE
Leander Lauffer · Gladenbach, DE
Friedrich-Robert Seiler · Marburg, DE

Key dates

Filing date	Jul 29, 1999
Grant date	Dec 11, 2001
Priority date	—
Expiry date	Jul 29, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The use of the IL-4 receptor for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections. The invention relates to the use of the IL-4 receptor or of derivatives thereof for the therapy, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and of fungal infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.